EZH2 and hepatocellular carcinoma: Inhibition of DNMT and EZH2 widely reduced DNA methylation and increased the chromatin accessibility in HCC cells.77 During liver-to-pancreas transdifferentiation, the accessibility of the pancreatic TFs binding motifs was increased, corresponding with reduced DNA methylation.